Can science birth artificial wombs? Lab-grown babies raise major ethical concerns



Since the first man, the human race has expanded and developed in a simple way: A man and a woman have sex, and a man's sperm fertilizes the woman's egg. Within four days of fertilization, a tiny cluster of cells begins to develop – the embryo. That embryo, which has now expanded to around 100 cells filled with fluid, travels along the fallopian tube and, within a week of conception, resides in the uterus, anchoring into the mother's body, growing by drawing nutrition from blood vessels and glands.

Within two months of conception, the embryo becomes a fetus and, after nine months, a baby. This is a miracle of human nature you likely learned in science class – and is solely down to the wonder of a mother's womb.

Infertility rates are rising by 1% every year in men. "By 2045, if that trend continues, the majority of couples would need reproductive assistance," Cohen says.

However, a minority of the scientific community have taken a different view. These scientists have a plan to remove the human from the post-conception process – to grow embryos independent of a womb and instead to nurture them artificially. The ability to independently develop a human being outside a mother's womb would have enormous ramifications for society and the human race. "What does it mean for society when we can produce children without any burden on women?" asks Maneesh Juneja, a digital health futurist. "It would have huge economic and societal effects."

Its potential has been backed by the likes of Tesla CEO and SpaceX founder Elon Musk and Ethereum co-founder Vitalik Buterin, who have both said that the development of artificial wombs could solve the world's imminent population crisis.

The potential ramifications of this research are so significant that there are plenty of competing projects to try to bring artificial wombs out of the laboratory and into reality. Exo-Genesis, a community looking to promote the development of extra-uterine devices that can grow human babies in vitro, held its first in-person meetup in San Francisco in late February. Among the attendees was Divya Cohen, a medical doctor, MBA, and MPA with nearly two decades of experience in health tech startups. "I feel very strongly that we need to make this a reality," says Cohen.

About 13% of women want to be mothers but don't want to go through pregnancy. Infertility rates are rising by 1% every year in men. "By 2045, if that trend continues, the majority of couples would need reproductive assistance," Cohen says. "This isn't the only technology that would be useful, but it's certainly a tool."

Technological wombs

gremlin/getty

It's a technology that is reportedly being developed in university laboratories around the globe. China's Suzhou Institute of Biomedical Engineering and Technology claimed to have developed an AI-based technology that can nanny human embryos in artificial wombs by monitoring levels of nutrition and carbon dioxide in artificial environments that help grow embryos to term – a key issue in previous experiments that have tried to develop embryos outside a natural womb. The goal of the AI is to mimic the inexplicable alterations and changes that a mother's body subconsciously undergoes to nurture an embryo throughout pregnancy – and that is easier said than done.

While AI gained plenty of attention and many news stories, the reality is more prosaic: The technology hasn't been tested in humans. Despite the splashy headlines, it isn't guaranteed to be all that effective.

One project at the forefront of artificial womb development – one of three papers discussed at the Exo-Genesis meeting in San Francisco – was based in the Weizmann Institute of Science in Rehovot, Israel. Alejandro Aguilera Castrejon is the lead author of the project to gestate a mouse embryo.

"The goal is to inject human cells into embryos to create chimeric models," says Aguilera Castrejon. So-called chimeric models, where human cells are injected into the embryos of other species and then tracked to model as closely as possible what would happen to the human cells in the embryonic stage, are used because it's impossible to conduct laboratory tests on human embryos.

Prior experiments had allowed similar chimeric-modeled embryos for two days – but Aguilera Castrejon's carefully monitored conditions permitted the embryo to grow for six days after it was implanted into a mouse, five days after fertilization. He and his colleagues are now working on starting the same process to grow embryos from day zero of fertilization rather than day five. The hope is that similar methods can be applied to humans. But there are some issues. The mouse embryos Aguilera Castrejon works with die after day eleven of the fertilization process because they become too big, preventing the oxygen and nutrients that would help them grow further from entering the embryo. "They basically die," he says.

That problem with mouse embryos is likely to be compounded with humans. Another challenge Aguilera Castrejon and his colleagues faced was keeping the embryo free of infection and contamination – an issue exacerbated should a similar experiment take place with human embryos because they take longer to develop. A mouse pregnancy lasts twenty days; humans, nine months. "The longer you have the embryo in culture, there are more things that can go wrong," he says.

The 29-year-old researcher, who has been working on his project for five years, believes that artificial human wombs are a while off. "In mice, I would say maybe it'll be a reality in ten years," he says. In humans? "I don't think I'll live to see humans," he says.

Aguilera Castrejon believes it'll take "at least fifty years" for science to bring a human embryo to full term and that it's not just the technological and biological challenges of doing so that are preventing development. In Israel, even if Aguilera Castrejon and his colleagues at the Weizmann Institute had the technical knowledge to grow a human embryo for the first month of its formation, they couldn't. "Maybe at some point society will advance to allow us to be born outside the uterus," he says. "I think technically this will be possible, but the main limit is the ethical aspect."

Regulations are being removed

In May 2021, the stem cell research community's public voice, the International Society for Stem Cell Research, dropped a rule that had previously prevented human embryos from being cultured for more than fourteen days. Some concerns remain about mixing human stem cells and non-human embryos in chimeric models – most recently over a 2021 U.S.-China project that combined humans with macaque monkeys – but there is a growing acknowledgment that such experiments are necessary steps for the future of fertility.

While Aguilera Castrejon is pessimistic that babies grown outside their mothers' wombs will be born in his lifetime, he does see a shift in attitudes, even in his five years in the field. For Cohen, the conversation must move beyond the field into the wider world. When she brings up the topic with her friends in science, they too often don't know about the risk of a potential population crisis. "We want [the rate of population replacement] to be 2.1, but in the U.S. it's 1.6, and in Japan it's 1.3," she says. "That means that we are very quickly turning into an upside-down pyramid society. If that continues, we're going to be in serious trouble by then. I think we could see a future similar to 'The Handmaid's Tale.' I used to read that book and thought it would never happen – but now the science suggests it could happen."

As for Aguilera Castrejon's skepticism about whether it's possible in his lifetime, Cohen says that we need less talking and more action. "I'm worried we're seeing a trend where that's going to hit us in 2045, and there are two alternatives," she says. "One is we get into this scary dystopian future, or we start working on the science and building what would help us outmaneuver that."

US regulators may soon approve human trials of artificial wombs



Advisers to the U.S. Food and Drug Administration are convening Tuesday and Wednesday for closed-door meetings to discuss the prospect of approving artificial wombs for use in human trials. The FDA's Pediatric Advisory Committee will chiefly address what kind of data scientists will have to produce in the trials and what sort of regulations may be needed.

The unnatural process by which a creature is grown inside a fluid-filled pod, as opposed to inside a symbiotic mother, has been pitched by companies like Vitara Biomedical as a means of increasing survival and improving outcomes for premature babies.

While some scientists are excited by the prospect of potentially helping struggling babies, critics have noted the technology will inevitably result in legal and ethical quandaries.

Nevertheless, Nature reported that researchers at the Children's Hospital of Philadelphia — a hospital that apparently offers medical sex-change interventions to children as young as 8 — are ready to move on from performing artificial womb experiments involving lambs. The lamb CHOP researchers are specifically seeking approval for the first human clinical trials of their extra-uterine environment for newborn development, or EXTEND.

This early technology would not yet entirely eliminate the mother from the equation. Rather than growing a human being from conception to birth, as was horrifyingly depicted in the science fiction film "The Matrix," the CHOP researchers "hope that simulating some elements of a natural womb will increase survival and improve outcomes for extremely premature babies. In humans, that's anything earlier than 28 weeks of gestation — less than 70% of the way to full term, which is typically between 37 and 40 weeks," according to Nature.

Bloomberg reported that premature lambs kept inside the fake womb for up to four weeks were able to develop normally.

Scientists at the University of Toronto executed similar experiments but instead on fetal pigs, having concluded that "there are several questions that remain with regards to the feasibility of translating [fetal sheep] results to human subjects."

Alan Flake, a fetal surgeon at CHOP who has taken the lead on the effort to dehumanize pregnancy, predicted in a 2017 video, "If it’s as successful as we think it can be, ultimately, the majority of pregnancies that are predicted at-risk for extreme prematurity would be delivered early onto our system rather than being delivered premature onto a ventilator."

Recreating the Womb: New Hope for Premature Babiesyoutu.be

A number of CHOP researchers have since joined Vitara Biomedical, a startup that has raised $100 million to develop EXTEND, thanks in large part to First Spark Ventures, a venture capital firm co-founded by former Google CEO Eric Schmidt.

To transition a baby from its mother to the pod, doctors would perform a C-section, albeit of a more complicated variety.

To ensure the baby remains in a "fetus-like state," such that the digestive system does not activate and fluid doesn't drain from its lungs, the surgeons must jab tubes into the baby's umbilical blood vessels then immediately dunk it into a so-called "biobag" filled with a sterile fluid that mimics that found in a real amniotic sack.

The tubes that had been inserted into the baby's umbilical blood vessels would provide it with nutrition, while a so-called membrane oxygenator would provide the baby with oxygen.

George Mychaliska, a pediatric fetal surgeon and researcher at the University of Michigan, told Bloomberg, "It makes sense that if you recreate the fetal environment, babies’ survival rate will increase and, hopefully, their long-term morbidities or health consequences will be diminished."

Nature indicated that there may be implications for abortion and its legality, particularly since fake wombs might make it such that fetal viability extends far earlier than currently recognized.

Earlier this year, pro-abortion radicals noted in Wired that while so-called ectogenesis would "enable people with wombs to reproduce as easily as cisgender men do: without risks to their physical health, their economic safety, or their bodily autonomy," the technology "could significantly weaken abortion policies worldwide."

The article's authors, Rosalind Moran and Jolie Zhou, bemoaned the possibility that without recourse to the "my body, my choice," argument, it may no longer be socially acceptable or legal for women to slaughter their unborn babies.

"Successful ectogenesis would render the fetus viable at a very early stage, possibly even from conception. If ectogenesis—even partial ectogenesis—becomes available, it would then be possible for an unwanted fetus to be transferred into an artificial womb to continue developing without harming a woman’s bodily autonomy, depending on how the fetus is removed," the two pro-abortion radicals wrote. "In this way, women would be able to end their pregnancy without resorting to traditional abortion. Given this option, if a woman chooses traditional abortion regardless, the abortion will appear more like an intentional killing."

Just as the new technology might prove lifesaving, to Zhou and Moran's dismay, it could alternatively expose the unborn grown in scientists' glorified Ziploc bags to various abuses on account of inevitable legal loopholes.

Chloe Romanis, a biolawyer at Durham Law School in the United Kingdom, told Nature that the babies grown in the fake wombs will not be fetuses in the conventional sense.

"The name we give to these new unprecedented patients has implications for rights that the law and society affords," said Romanis.

The FDA advisory meeting takes place at a time in American medicine when it appears many are keen to separate babies from their mothers or, at the very least, pregnancy from women.

In June, the American Medical Association published a peer-reviewed paper in its Journal of Ethics floating the suggestion that there's no moral reason why taxpayers should not subsidize the provision of wombs from dead or living women to transvestites so that they can carry babies.

Could artificial wombs help save premature babies?youtu.be

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!